CHRISTY HELTZEL: Open Payments
NPI 1831604545 · SEWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 23 payments from 12 companies in 2025. Trend: 2023 $14 · 2024 $595 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $141 |
| Lilly USA, LLC | 2 | $41 |
| QOL Medical, LLC | 1 | $26 |
| Novo Nordisk Inc | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Celltrion USA Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: RINVOQ, OMVOH, LINZESS, Sucraid, Wegovy, TREMFYA, IBSRELA, ENTYVIO.
Industry payments across NJ — which companies pay providers there.
